4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001209191-23-058943
President and CFO sold 14,000 shares at $60.22 ($843,080)
- President and CFO acquired 14,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GUGGENHIME ANDREW President and CFO | 2023-12-14 | Option exercise 10b5-1 | +14,000 | $5.35 | $74,900 | 93,474 | D |
| GUGGENHIME ANDREW President and CFO | 2023-12-14 | Sale 10b5-1 | −14,000 | $60.22 | $843,080 | 79,474 | D |
| Derivatives | |||||||
| GUGGENHIME ANDREW President and CFO | 2023-12-14 | Option exercise · Stock Option (right to buy) 10b5-1 | −14,000 | 400,827 | D | ||
| Open-market sales · 14,000 sh · avg $60.22 · $843,080 | |||||||
Loading xslF345X05/doc4.xml…